Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk

Ann Pharmacother. 2021 Jul 30:10600280211036047. doi: 10.1177/10600280211036047. Online ahead of print.NO ABSTRACTPMID:34330173 | DOI:10.1177/10600280211036047

https://pubmed.ncbi.nlm.nih.gov/34330173/?utm_source=no_user_agent&utm_medium=rs...

Source: The Annals of Pharmacotherapy - July 31, 2021 Category: Drugs & Pharmacology Authors: Xian Jie Cindy Chen Diana Altshuler Peter Spiegler Shari B Brosnahan Source Type: research

More News: Actemra | Corticosteroid Therapy | COVID-19 | Drugs & Pharmacology | Respiratory Medicine